07-Apr-2026
Download PDF
Aurobindo Pharma
Submission of Press Release on receipt of USFDA approval for Dapagliflozin and Metformin Hydrochloride Extended-Release tablets.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
